Has Donald Hohman, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,025,516 in general payments to Donald Hohman, MD across 424 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Donald Hohman, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Donald Hohman, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Donald Hohman, MD

Adult Reconstructive Orthopaedic Surgery · Dallas, TXNPI 1801235833

Payments from drug & device makers

$1,025,516in general payments, 2019–2025

Across 424 payments — averaging $2418.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Kyocera Medical Technologies, Inc.$518K
Sanara Medtech Inc.$104K
Limacorporate S.p.a.$86K
Advanced Orthopaedic Solutions, Inc.$79K
Arthrex$57K
Encore Medical, LP$43K
plus $138K from 38 others

$13,700in research payments, 2019–2025

Across 4 payments — averaging $3425.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Omnilife Science, Inc$14K

What the payments were for

Royalty or licence$19,4374%
Consulting fees$347,35265%
Speaking & faculty fees$88,67517%
Travel & lodging$66,73812%
Food & beverage$12,6002%
Gifts$1140%
Other$2,4900%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Kyocera Medical Technologies, Inc.	25	$517,928
Sanara Medtech Inc.	73	$104,290
Limacorporate S.p.a.	34	$85,706
Advanced Orthopaedic Solutions, Inc.	24	$79,366
Arthrex	8	$56,926
Encore Medical, LP	52	$43,053
Lima USA, Inc.	24	$23,525
Orthalign Inc	47	$21,696
Signature Orthopaedics USA Corp	2	$19,437
Medical Device Business Services, Inc.	13	$16,254
UOC USA Inc	5	$13,995
Corin USA	8	$11,561
Wound Management Technologies, Inc	6	$11,102
Depuy Synthes Products, Inc.	10	$7,986
Omnilife Science, Inc	10	$3,977
Engage Uni, LLC	9	$2,814
Acera Surgical, Inc.	1	$2,490
Bone Support Inc.	8	$832
Biocomposites Inc	7	$485
Stryker	3	$244
Conformis, Inc.	3	$240
Pylant Medical	6	$211
Smith+Nephew	5	$154
DJO, LLC	2	$151
Kinamed, Inc.	1	$123
Seaspine Orthopedics Corporation	1	$122
Johnson & Johnson(2 entities)	6	$97
Davol Inc.	4	$95
Innovation Technologies Inc	3	$93
Carbofix Orthopedics Inc	1	$92
Zimmer Biomet	3	$59
BD	1	$51
Amgen	3	$50
Kerecis Limited	2	$45
Bioventus LLC	2	$44
Pacira Pharmaceuticals Incorporated	2	$40
Ferring Pharmaceuticals Inc.	2	$37
Integra Lifesciences Corporation	1	$37
Cumberland Pharmaceuticals, Inc.	2	$31
Convatec Inc.	1	$29
My01 Inc.	1	$15
Ossur Americas, Inc.	1	$13
Kowa Pharmaceuticals America, Inc.	1	$13
Osteoremedies, LLC	1	$6

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CellerateRx$110,155
Physica$99,071
AOS PRODUCTS$50,828
DJO Surgical TaperFill Hip System$36,945
Trochanteric Nail$28,400
DJO Surgical Empowr Knee System$22,985
OrthAlign Plus System$18,585
DJO SURGICAL$10,009
UMS U3$9,696
PHYSICA CR$9,400
DJO Surgical FMP Acetabular System$4,200
Conformity, U-Star II, U2$4,200
Biasurge$4,175
Engage Partial Knee System$2,814
ORTHALIGN PLUS$2,494
Restrata Wound Matrix$2,490
Velys$1,352
OMNIBotics 3.0$1,000
UNITY TOTAL KNEE SYSTEM$1,000
CERAMENTBONE VOID FILLER$693

How this compares

$1,025,516 in reported general payments places this provider in the 95th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$429,361

Medicare patients

600

Services billed

4,541

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	74	$1,806
Gabapentin	93	$490
Oxycodone Hcl	72	$414
Tramadol Hcl	73	$316
Ondansetron Hcl	85	$255
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	13	$116
Amoxicillin	47	$71
Ondansetron OdtOndansetron	11	$58

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Dallas

Antonia ChenDallas$4.1M
Joel WellsDallas$103K
Bilal MahmoodDallas$33K
Justin CardenasDallas$29K
Tyler YoungmanDallas$8K
Tyler GoldbergAustin$4.6M
John BarringtonPlano$2.2M
Roger EmersonPlano$1M
Marcus FordFort Worth$401K
Steven WeedenFort Worth$370K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →